Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 1,621 - 1,640 results of 64,934 for search '(( 50 ((ng decrease) OR (a decrease)) ) OR ( 5 ((mg decrease) OR (we decrease)) ))', query time: 1.39s Refine Results
  1. 1621
    Supplementary file 1_Role and mechanism of IGFBP5 in the real-ambient particulate matter exposure-induced chronic lung injury.docx

    Supplementary file 1_Role and mechanism of IGFBP5 in the real-ambient particulate matter exposure-induced chronic lung injury.docx by Ningning Chen (509273)

    Published 2025
    “…Moreover, microRNAs (miRNAs) are an important class of gene expression regulators. We found that the upregulated hsa-miR-33a-5p repressed IGFBP5 translation by forming a silencing complex with Argonaute protein 2 (AGO2) in a real-ambient PM exposure system, which further led to the suppression of the ERK1/2-SOD2 signaling pathway and increased levels of ROS.…”
    Save to List
    Saved in:
  2. 1622
    FSS rescues homocysteine-caused the decrease of NO production in cultured HUVECs after the application of A23187.

    FSS rescues homocysteine-caused the decrease of NO production in cultured HUVECs after the application of A23187. by Cathy W. C. Bi (108697)

    Published 2012
    Save to List
    Saved in:
  3. 1623
    Heart specific RNase Z variants show a mild decrease in longevity and locomotor response.

    Heart specific RNase Z variants show a mild decrease in longevity and locomotor response. by Ekaterina Migunova (15909887)

    Published 2023
    Save to List
    Saved in:
  4. 1624
    Erratum: Decrease in Incidence of Bronchopulmonary Dysplasia with Erythropoietin Administration in Preterm Infants: A Retrospective Study

    Erratum: Decrease in Incidence of Bronchopulmonary Dysplasia with Erythropoietin Administration in Preterm Infants: A Retrospective Study by Rayjada N. (4272919)

    Published 2017
    “…<b><i>Objective:</i></b> To determine whether EPO treatment for AOP was associated with a reduced incidence of BPD in premature infants. …”
    Save to List
    Saved in:
  5. 1625
    Table_3_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.pdf

    Table_3_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  6. 1626
    Image_2_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.png

    Image_2_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  7. 1627
    Table_1_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.pdf

    Table_1_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  8. 1628
    Table_3_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.pdf

    Table_3_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  9. 1629
    Table_1_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.pdf

    Table_1_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  10. 1630
    Table_2_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.pdf

    Table_2_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  11. 1631
    Table_2_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.pdf

    Table_2_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  12. 1632
    Image_1_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.png

    Image_1_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  13. 1633
    Image_1_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.png

    Image_1_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  14. 1634
    Image_2_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.png

    Image_2_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  15. 1635
    Introduction of the F region decreases the amount of extracellular PSMs and increases the amount of extracellular FnbA.

    Introduction of the F region decreases the amount of extracellular PSMs and increases the amount of extracellular FnbA. by Chikara Kaito (230958)

    Published 2011
    Save to List
    Saved in:
  16. 1636
    In vitro CA4P toxicity assay.

    In vitro CA4P toxicity assay. by Anja Bille Bohn (641992)

    Published 2014
    Save to List
    Saved in:
  17. 1637
    Meta data to S5 Fig.

    Meta data to S5 Fig. by Xiaowen Jiang (8291814)

    Published 2024
    “…Using the zebrafish pectoral fin bud as a model for early vertebrate fin/limb development, we found that K<sup>+</sup> channels also scale this anatomical structure, and we determined how one K<sup>+</sup>-leak channel, Kcnk5b, integrates into its developmental program. …”
    Save to List
    Saved in:
  18. 1638
    Meta data to Fig 5.

    Meta data to Fig 5. by Xiaowen Jiang (8291814)

    Published 2024
    “…Using the zebrafish pectoral fin bud as a model for early vertebrate fin/limb development, we found that K<sup>+</sup> channels also scale this anatomical structure, and we determined how one K<sup>+</sup>-leak channel, Kcnk5b, integrates into its developmental program. …”
    Save to List
    Saved in:
  19. 1639
    Local but Not Systemic Administration of Uridine Prevents Development of Antigen-Induced Arthritis

    Local but Not Systemic Administration of Uridine Prevents Development of Antigen-Induced Arthritis by Sudeep Chenna Narendra (819743)

    Published 2015
    “…In contrast, systemic administration of uridine (max 1.5 mg uridine per day) did not prevent development of arthritis. …”
    Save to List
    Saved in:
  20. 1640
    βL decreases body mass.

    βL decreases body mass. by Jeong-sook Lee (127654)

    Published 2012
    Save to List
    Saved in:

Search Tools: